Viewing Study NCT03946358


Ignite Creation Date: 2025-12-25 @ 12:06 AM
Ignite Modification Date: 2026-01-10 @ 6:39 PM
Study NCT ID: NCT03946358
Status: COMPLETED
Last Update Posted: 2024-12-20
First Post: 2019-05-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL)
Sponsor: Centre Hospitalier Universitaire de Besancon
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module